John Hill, MD Department of Hematology and Medical Oncology, The ClevelandClinic
Halle Moore, MD Associate Professor, Department of Hematology and Clinical Oncology, The Cleveland Clinic
Address: Halle Moore, MD, Department of Hematology and Medical Oncology, R35, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail mooreh1@ccf.org
This paper discusses treatments that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.
ABSTRACTThe aromatase inhibitors are established first-line drugs for treating metastatic breast cancer in postmenopausal women, and are gaining acceptance as adjuvant treatment as well.
